Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Animal- and Human-Based Evidence for the Protective Effects of Stem Cell Therapy Against Cardiovascular Disorders Publisher Pubmed



Pooria A1 ; Pourya A2 ; Gheini A1
Authors

Source: Journal of Cellular Physiology Published:2019


Abstract

The increasing rate of mortality and morbidity because of cardiac diseases has called for efficient therapeutic needs. With the advancement in cell-based therapies, stem cells are abundantly studied in this area. Nearly, all sources of stem cells are experimented to treat cardiac injuries. Tissue engineering has also backed this technique by providing an advantageous platform to improve stem cell therapy. After in vitro studies, primary treatment-based research studies comprise small and large animal studies. Furthermore, these studies are implemented in human models in the form of clinical trials. Purpose of this review is to highlight the animal- and human-based studies, exploiting various stem cell sources, to treat cardiovascular disorders. © 2019 Wiley Periodicals, Inc.
Related Docs
View other Related Docs
1. Stem Cells and Heart Tissue Regeneration, Nanomedicine for Ischemic Cardiomyopathy: Progress# Opportunities# and Challenges (2020)
2. Current Status of Stem Cell Therapy and Nanofibrous Scaffolds in Cardiovascular Tissue Engineering, Regenerative Engineering and Translational Medicine (2022)
3. Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases, Journal of Cellular Biochemistry (2018)
Experts (# of related papers)
View all Related Experts
Abdolmohammad Kajbafzadeh (3)
Shahram Rabbani (2)
Other Related Docs
4. Regenerative Strategies for the Consequences of Myocardial Infarction: Chronological Indication and Upcoming Visions, Biomedicine and Pharmacotherapy (2022)
5. Stem Cell Therapies for Congenital Heart Disease, Biomedicine and Pharmacotherapy (2016)
6. Regenerative Medicine for the Treatment of Ischemic Heart Disease; Status and Future Perspectives, Frontiers in Cell and Developmental Biology (2021)
7. Whole-Heart Tissue Engineering and Cardiac Patches: Challenges and Promises, Bioengineering (2023)
8. Application of Stem Cell Technologies to Regenerate Injured Myocardium and Improve Cardiac Function, Cellular Physiology and Biochemistry (2019)
9. Cells, Scaffolds and Their Interactions in Myocardial Tissue Regeneration, Journal of Cellular Biochemistry (2017)
10. Regulation of Cardiac Stem Cells by Micrornas: State-Of-The-Art, Biomedicine and Pharmacotherapy (2019)
11. Cardiac Extracellular Matrix Hydrogel Together With or Without Inducer Cocktail Improves Human Adipose Tissue-Derived Stem Cells Differentiation Into Cardiomyocyte–Like Cells, Biochemical and Biophysical Research Communications (2018)
12. Recent Advances in Cardiac Regeneration: Stem Cell, Biomaterial and Growth Factors, Biomedicine and Pharmacotherapy (2017)
13. Inflammatory Microenvironment of Acute Myocardial Infarction Prevents Regeneration of Heart With Stem Cells Therapy, Cellular Physiology and Biochemistry (2019)
14. Review Insights in Cardiac Tissue Engineering: Cells, Scaffolds and Pharmacological Agents, Iranian Journal of Pharmaceutical Research (2021)
15. Myocardial Cell Signaling During the Transition to Heart Failure: Cellular Signaling and Therapeutic Approaches, Comprehensive Physiology (2019)
16. Improvement of Heart Function After Transplantation of Encapsulated Stem Cells Induced With Mir-1/Myocd in Myocardial Infarction Model of Rat, Cell Transplantation (2021)
17. Micrornas and Exosomes: Cardiac Stem Cells in Heart Diseases, Pathology Research and Practice (2022)
18. Cellular and Molecular Characterization of Human Cardiac Stem Cells Reveals Key Features Essential for Their Function and Safety, Stem Cells and Development (2015)
19. Cardiac Extracellular Matrix As a Platform for Heart Organ Bioengineering: Design and Development of Tissue-Engineered Heart, Advances in Experimental Medicine and Biology (2021)
20. Evaluating the Efficacy of Tissue-Engineered Human Amniotic Membrane in the Treatment of Myocardial Infarction, Regenerative Medicine (2019)